Skip to content

Blood tests for long-term health and longevity

For people who track their blood tests over the years to look after long-term health, whether or not they have a condition.

11 tests explainedAI-verified against cited sources. Awaiting expert reviewLast reviewed 2026-10-19

For long-term tracking, some tests have strong guideline support and others rest on weaker evidence. ApoB and Lp(a) now appear in the 2026 U.S. cholesterol guideline. Fasting insulin, HOMA-IR and the omega-3 index rest on weaker evidence or less consistent lab methods. More tests also bring more results outside the range by chance.

The tests that matter most

Most important first. Each one links to its full page, where the note for this group sits near the top.

  • Apolipoprotein B (ApoB)

    The 2026 U.S. cholesterol guideline counts a high ApoB as a factor that adds to heart risk, and says ApoB predicts risk better than LDL when the two disagree. For people on cholesterol treatment, it finds ApoB useful once LDL and non-HDL goals are met.

    Source: Circulation (2026)

    Usual adult range
    up to 90 mg/dL
  • Lipoprotein(a), molar (nmol/L)

    Lp(a) is mostly inherited. The 2026 U.S. cholesterol guideline newly recommends measuring it at least once in all adults, and counts a high level as a factor that adds to heart risk. One test is generally enough unless something can shift the level, such as the menopause transition or kidney, liver or thyroid disease.

    Source: Circulation (2026)

    Usual adult range
    up to 75 nmol/L
  • C-Reactive Protein (CRP, incl. hs-CRP)

    If high-sensitivity CRP (hs-CRP) is measured, the 2026 U.S. cholesterol guideline counts a level of 2 mg/L or more on more than one occasion, with no other cause found, as a factor that adds to heart risk.

    Source: Circulation (2026)

    Usual adult range
    0–5 mg/L
  • Hemoglobin A1c (HbA1c)

    The ADA suggests diabetes screening for all adults starting at age 35, repeated at least every 3 years when results are normal and yearly with prediabetes. A1c can mislead with anemia, recent blood loss or some hemoglobin variants, and the ADA suggests glucose-based criteria in those cases.

    Source: American Diabetes Association (2026)

    Usual adult range
    4.8–5.6 %
  • eGFR (Creatinine + Cystatin C, CKD-EPI 2021)

    Creatinine depends on muscle and diet, so people who do extreme sport or bodybuilding, eat a high-protein diet or take creatine supplements can get a misleading creatinine-based eGFR. KDIGO recommends adding cystatin C when the creatinine-based result is less accurate and would affect decisions.

    Source: Kidney Disease: Improving Global Outcomes (2024)

    Usual adult range
    60 and above mL/min/1.73 m²
  • Insulin

    An ADA workgroup reported in 2010 that commercial insulin tests give a range of values for the same sample, so fasting insulin results from different labs are not directly comparable. A 2023 international guideline on PCOS (also called PMOS) says insulin tests in clinical use are of limited value and not recommended in routine PCOS care.

    Sources: Diabetes Care (2010) and The Journal of Clinical Endocrinology & Metabolism (2023)

    Usual adult range
    2.6–24.9 µIU/mL
  • HOMA-IR

    HOMA-IR is worked out from fasting insulin and glucose, so it carries the same lab-to-lab problem. In 2010, an ADA workgroup said insulin sensitivity measures were used only in research, had no clinical applications yet, and gave results that were not comparable from one study to the next.

    Source: Diabetes Care (2010)

  • Alanine Aminotransferase (ALT)

    ALT is a liver enzyme on standard blood panels, and it is often ordered with GGT and other liver tests. Hard exercise before a test is one of the things MedlinePlus lists as able to change lab results.

    Sources: MedlinePlus and MedlinePlus

    Men, 18+
    0–44 U/L
    Women, 18+
    0–32 U/L
  • Gamma-Glutamyl Transferase (GGT)

    GGT is a liver enzyme that alcohol raises. Smoking, some medicines and supplements, and conditions such as diabetes and heart failure can also affect it, so a high GGT on its own doesn't show the cause.

    Source: MedlinePlus

    Men, 18+
    0–65 U/L
    Women, 18+
    0–60 U/L
  • Vitamin D (25-Hydroxy)

    The Endocrine Society suggests against routine vitamin D testing in the general population at every adult age. It also says the vitamin D levels that bring specific health benefits have not been set in clinical trials.

    Source: Endocrine Society (2024)

    Usual adult range
    30–100 ng/mL
  • Omega-3 Index (EPA+DHA)

    A pooled analysis of 17 cohort studies linked higher blood levels of EPA and DHA, the two omega-3 fats this test adds up, with a lower risk of death. It measured them in red cells or plasma rather than reporting the omega-3 index by name, and as an observational study it can't rule out that higher levels partly reflect a healthy lifestyle.

    Source: Nature Communications (2021)

Ranges shown are the usual adult ranges labs print. The range on your own report is the one your result is judged against.

Getting results you can compare

  • For trends, use the same lab when you can. MedlinePlus notes that labs often use different methods and ranges, so results from different labs can't be compared directly. This is a particular issue for fasting insulin and HOMA-IR, since a 2010 ADA workgroup found insulin tests give different values for the same sample.

    Sources: MedlinePlus and Diabetes Care (2010)

  • Foods and drinks, medicines, supplements and hard exercise before a test can all shift results, MedlinePlus says. Keeping test-day habits the same makes changes over time easier to trust.

    Source: MedlinePlus

Good to know

  • Many 'optimal' targets rest on limited evidence. The Endocrine Society says vitamin D levels with proven benefits haven't been established. A 2010 ADA workgroup said insulin sensitivity measures had no clinical use yet, and a 2023 PCOS guideline calls insulin tests of limited clinical value. The omega-3 links come from observational studies.

    Sources: Endocrine Society (2024), Diabetes Care (2010), The Journal of Clinical Endocrinology & Metabolism (2023) and Nature Communications (2021)

  • More tests mean more results outside the range by chance. Reference ranges come from large groups of healthy people, and MedlinePlus notes it's common for healthy people to sometimes have results outside them. Your clinician can put a single flag in context.

    Source: MedlinePlus

Questions you could ask

  • Which of these tests could change a decision about my care?
  • Has my Lp(a) been measured, and does it need repeating?
  • Would cystatin C give a clearer picture of my kidney function?
  • How should we read a result that's just outside the range?
  • Which tests are worth repeating, and how often?

Sources

  1. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia, Circulation (2026)
  2. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2026, American Diabetes Association (2026)
  3. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, Kidney Disease: Improving Global Outcomes (2024)
  4. Insulin Assay Standardization: Leading to measures of insulin sensitivity and secretion for practical clinical care, Diabetes Care (2010)
  5. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome, The Journal of Clinical Endocrinology & Metabolism (2023)
  6. Gamma-glutamyl Transferase (GGT) Test, MedlinePlus
  7. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline, Endocrine Society (2024)
  8. Blood n-3 fatty acid levels and total and cause-specific mortality from 17 prospective studies, Nature Communications (2021)
  9. How to Understand Your Lab Results, MedlinePlus

AI-verified against cited sources. Awaiting expert review. Last reviewed 2026-10-19. How we build and check these pages.

Educational information, not medical advice. Blood Test Tracker doesn’t diagnose or treat, and it doesn’t replace your clinician. Talk with your clinician before changing medications, supplements or care.

Also written for